Is Weed Legal in Lesotho? Understanding Lesotho Cannabis and Marijuana Laws (2026)

Lesotho permits licensed cannabis production for medical and scientific purposes, but it has not legalized recreational use or unlicensed home cultivation. Its export industry does not give residents or visitors a general right to buy cannabis. Equally, saying that every form of medical possession is prohibited overlooks exceptions in the country’s drugs law.

The practical distinction is between authorized medical or scientific activity and unauthorized personal or commercial activity. Licensing, product approvals, prescription requirements, and border permissions need to be assessed separately.

Is Weed Legal in Lesotho?

Recreational cannabis is not legal. Lesotho became an early African medicinal-cannabis producer when it began issuing industry licenses in 2017. Those licenses allow specified activities under government control; they do not establish a recreational dispensary system.

The legal foundation is the Drugs of Abuse Act, 2008, supplemented by cannabis regulations and other applicable medicines rules. Cannabis remains controlled. An export license, a patient’s prescription, and permission to cultivate are different authorizations.

What Does the Drugs of Abuse Act Allow?

The Act regulates production, supply, possession, and international movements of controlled drugs. Sections 11–13 provide for operator applications and licenses tied to specified activities and premises. The Minister must be satisfied about the applicant, supervision, premises, security, and medical or scientific purpose.

Import and export activity also requires the appropriate transaction permit. Under sections 14–15, this is separate from an operator license, and an export application requires the destination country’s import authorization. A Lesotho production license does not establish permission to sell into any foreign market.

Section 18 permits applications for scientific or strictly limited medical programs, subject to approval and conditions. These provisions mean that an export-oriented industry should not be described as the only legally possible medical activity in the country.

Can Local Patients Get Medical Cannabis?

The existence of licensed production does not demonstrate an accessible domestic pharmacy program. The sources reviewed for this guide do not establish a nationwide patient-card or cannabis-dispensary system.

However, the Drugs of Abuse Act includes controlled prescribing and professional-supply provisions, as well as permits for limited medical programs. It is too broad to say that the law provides no medical route at all. Whether a particular cannabis medicine can be prescribed, imported, or dispensed requires confirmation of the product and applicable approvals.

Patients should ask the Ministry of Health and the relevant medicines regulator about the specific preparation and authorized access pathway. A treatment need alone does not authorize home cultivation or purchase from an unlicensed seller.

Can You Grow Cannabis at Home?

There is no general personal home-growing allowance. Cultivation requires the relevant authorization and compliance with its conditions. Traditional cultivation or reports of uneven enforcement do not create an exemption from the law.

Lesotho is completely surrounded by South Africa, but South Africa’s private-use court protection does not extend across the border. Residents and visitors must follow Lesotho’s own rules.

What Changed in the 2025 Cannabis Regulations?

Mayet & Associates’ analysis of Legal Notice 155 of 2025, published on November 7, 2025, describes revised commercial import/export permits, testing-related requirements, Narcotics Bureau endorsement of export permits and destruction certificates, and a revised fee schedule.

The firm’s summary lists cultivation, manufacturing, and testing license fees of M100,000 each; an operator license at M400,000; supply and transportation licenses at M40,000 each; research at M50,000; and storage at M10,000. It lists renewal fees of M75,000 for cultivation, manufacturing, and testing, and M300,000 for an operator license.

These are fees for different permissions, not a single all-inclusive project price. Applicants also need to budget for inspections, premises, security, testing, and export compliance. Confirm the current applicable schedule and license combination directly with the authorities before committing funds.

Separately, the same law firm’s commencement update reports that the Lesotho Medicines and Medical Devices Control Authority Act, 2023 came into operation on March 1, 2026. That broader medicines reform should not be confused with recreational cannabis legalization.

How Does the Export Industry Work?

Lesotho’s investment case combines an established cultivation tradition with production for regulated medical markets. The Lesotho National Development Corporation promotes the medicinal-cannabis sector, but investment promotion is different from proof of a particular operator’s current license, certification, output, or profitability.

International investment accelerated during the early licensing period. Aphria announced a 2018 venture involving Verve Dynamics; Aphria later combined with Tilray, now Tilray Brands (TLRY ). Supreme Cannabis invested in Medigrow Lesotho, associated with the MG Health business. Canopy Growth (CGC ) announced its acquisition of Daddy Cann Lesotho in May 2018. These are historical transactions, not a current ownership register.

WeGROW also presents its business as medical-cannabis production and export. Buyers and investors should verify the current authorizations and quality documentation for the actual site and product they intend to use.

Foreign markets can impose manufacturing, testing, importer, and product requirements beyond a Lesotho license. Certification must match the relevant activities and destination market. Check certification for the producer and activity involved.

Has the Industry Benefited Small Farmers?

A 2024 study in the Journal of Cannabis Research identified barriers facing smaller enterprises and traditional growers, including the cost of compliance and limited participation in the regulated sector. Its company-registration and GMP counts describe the study period, not a continuously updated register.

The distinction matters when assessing economic claims. A projected industry value, a license issued, an investment announced, and export revenue actually earned are different measures. None alone establishes how income is distributed among local workers, farmers, investors, and the state.

Business risks are also visible in historical cases. In July 2022, Akanda Corp. (AKAN ) reported a court-ordered liquidation of Bophelo Bio Science & Wellness and said it would contest the action. This is a dated company account of that dispute, not a statement of the proceedings’ current status.

Our earlier coverage of Lesotho’s pioneering industry and its difficulties explores that broader tension. Current assessments should focus on operating businesses, compliance, employment conditions, and benefits reaching communities.

What About Traditional Cannabis Varieties?

Cannabis, commonly called matekoane, has a longstanding place in Lesotho’s cultivation economy. That history is relevant to discussions about participation by traditional growers and benefits from local genetic resources.

A regional strain name is not a laboratory specification. It cannot establish a consistent THC or THCV concentration, genetic purity, or a guaranteed effect. Claims about a particular seed line or finished product require evidence specific to that material.

Can Travelers Carry Prescribed Cannabis Medicine?

Section 10 of the Drugs of Abuse Act expressly addresses international travelers undergoing medical treatment. It permits possession of reasonably required quantities of a prescribed drug of abuse when entering, leaving, or passing through Lesotho.

That provision makes a blanket statement that prescribed controlled medicine can never be carried into Lesotho inaccurate. It is not an unrestricted cannabis-import permission: travelers should confirm how the provision applies to their particular medicine, documentation, and quantity with the Ministry of Health and border authorities before travel.

A foreign medical card, a CBD label, or legal purchase in South Africa does not by itself settle those questions. CBD preparations should likewise be assessed for their ingredients and regulatory status rather than assumed automatically prohibited or unrestricted.

What Is the Outlook?

Lesotho’s cannabis framework continues to center on controlled medical and scientific activity. Its licensing reforms and wider medicines oversight do not create a recreational market or general home-growing right.

For operators, the next practical steps depend on the specific licenses, premises, products, and destination markets. For patients, they depend on an authorized medical pathway. Keeping these distinctions clear gives a more useful picture than treating an export industry as either full legalization or a ban on every medical use.